A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients
Not applicable · Testing Gut directed hypnotherapy via telephone intervention and Educational recording · 1 site · Stanford University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Gut directed hypnotherapy via telephone intervention (a behavioral program) and Educational recording (a behavioral program) as a possible treatment. Condition(s) listed: Disorders of Gut-brain Interaction, Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome.
Participants are assigned to groups by chance (randomized).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Adults admitted to the GI inpatient service with expected length of stay >24 hours
- Prior diagnosis of a disorder of gut-brain interaction, esophageal disorder, or inflammatory bowel disease
- Reason for hospitalization related to symptom management for exacerbation of visceral pain and/or nausea.
There are also 7 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 26 participants are expected to take part.
- Start date: 2026-07 (planned).
- Main results expected around 2027-07 (estimate from the record).
- 1 study site listed in United States.
Main thing being measured
- Recruitment rate (Up to 1 year.)
In the researchers’ words
The purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and/or nausea will be considered for enrollment.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Disorders of Gut-brain Interaction; Inflammatory Bowel Disease (IBD); Irritable Bowel Syndrome; Abdominal Pain; Esophageal Disease |
| Lead sponsor | Stanford University |
| Collaborators | American College of Gastroenterology |
| Enrollment | 26 (estimated) |
| Start date | 2026-07 |
| Primary completion (est.) | 2027-07 |
| First posted | 2026-06-30 |
| Last updated | 2026-06-30 |
| Official title | A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients |
| ClinicalTrials.gov ID | NCT07676136 |
Interventions
- Gut directed hypnotherapy via telephone intervention (Behavioral)
Participants will undergo a self-directed gut-directed hypnosis intervention over the telephone. - Educational recording (Behavioral)
Participants will listen to educational material over the telephone about their gastrointestinal symptoms.
Full eligibility criteria (from the record)
Inclusion Criteria: * Adults admitted to the GI inpatient service with expected length of stay >24 hours * Prior diagnosis of a disorder of gut-brain interaction, esophageal disorder, or inflammatory bowel disease * Reason for hospitalization related to symptom management for exacerbation of visceral pain and/or nausea. Exclusion Criteria: * Currently using hypnosis * severe developmental delay or cognitive impairment * serious mental illness (i.e. psychosis or dissociation) * hearing impairment * Non-English speaking * enrolled in another trial for GI symptom management * admitted for GI procedure
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University | Stanford, California | United States |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.